Accessible instruments / Point-of-care diagnostics / Seed
A clinical analyzer reduced to light, inference, and a $38.50 bill of materials.
Metric impact
42x
lower cost per panel
98.4% lab concordance
Founders
Dr. Ananya Rao / Marcus Vance
Stage
Seed
Replaces
$180,000 benchtop clinical analyzer
Investment memorandum / 01
Scattr brings laboratory-grade blood analysis to the point of care by replacing optical complexity with computational speckle interferometry.
Technical insight
Conventional blood analysis depends on diffraction gratings, refrigerated transport, and large benchtop instruments. Scattr uses a single 650nm laser diode to pass coherent light through a fluid sample and records the resulting scatter pattern on an un-lensed consumer image sensor.
Its compact spatial neural networks solve the inverse phase-retrieval problem in real time. Cellular deformation, protein aggregation, and viral load are inferred directly from noisy optical interference, moving the precision into software and the result to the patient.
Commodity hardware base
Measured deployment
140
rural care centers
80 sec
full panel result
$1.10
cost per run
98.4%
lab concordance
Capability per deployed dollar
Scattr has delivered full metabolic and hematology panels across rural primary care centers without cold-chain transport or specialized laboratory operators.
Legacy architecture
$180,000 capital expenditure, with turnaround measured in days
Tensor architecture
$38.50 hardware footprint, with an 80-second point-of-care result
Next company / 02